Ravi Sharad Lakdawala, M.D.

Education and Training

2008	B.A., Medical Sciences – Cum Laude Minor in Economics Boston University Boston, MA
2011	Doctor of Medicine Boston University School of Medicine Boston, MA
2011-2012	Internship - Internal Medicine Boston University/ Boston Medical Center Boston MA
2012-2014	Residency – Internal Medicine Boston University/ Boston Medical Center Boston, MA
2014-2016	Fellowship - Nephrology LAC+USC Medical Center Los Angeles, CA

Licensure and Certification

Medical Board of California Licensure: 2014
American Board of Internal Medicine Certification: 2014

Memberships in Professional Societies

American Society of Nephrology
National Kidney Foundation

Honors

Ariel Weisman Teaching Award
Outstanding Achievement in Clinical Teaching
Boston University Medical Campus

Clinical Study Location

Tower Nephrology Medical Group, 8635 West 3rd Street Suite 485W Los Angeles, CA 90048

DaVita of Beverly Hills, 50 N. La Cienega Blvd. #300 Beverly Hills, CA 90211

DaVita of Crescent Heights, 8151 Beverly Blvd Los Angeles, CA 90048

Clinical Studies

Sub-Investigator	*2016	ICH Good Clinical Practice for Clinical Trail Sites (Certificates)
Sub-Investigator	2016	A Phase 3 Randomized, Open-Label (Sponsor-Blind), Active-Controlled, Parallel-Group, Multi-Center, Event Driven Study in Dialysis Subjects with Anemia Associated with Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch from Erythopoietin- Stimulating Agents.
Sub-Investigator	2016	A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, active Control Study to Demonstrate the Safey and Effectiveness of Neutrolin in Preventing Catheter-Related Bloodstream infections in Subjects receiving Hemodialysis Therapy as treatment for End Stage Renal Disease
Sub-Investigator	2016	Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects with Non-Dependent Chronic Kidney Disease (NDD-CKD) (Pro2tect – Conversion)
2014		Quality Improvement Research Developed, studied, and executed a process to improve the transition from the inpatient setting to the affiliated outpatient dialysis unit for dialysis patients at LAC+USC Medical Center. LAC+USC Medical Center, Los Angeles, CA
2012		Quality Improvement Research Developed, studied, and executed a process to decrease the time to first antibiotic administration for septic patients in the inpatient wards at Boston Medical Center. Presented to the Boston Medical Center Department of Medicine and the Quality Improvement Department. Boston Medical Center, Boston, MA

Publications

Lakdawala RS and Abdelmalek JA. “IgA Nephropathy.” Medicine Morning Report: Beyond the Pearls. Ed. Dasgupta R and Koolaee RM. (Pending book publication, September 2015)
Lakdawala RS and Abdelmalek JA. “Nephrolithiasis.” Medicine Morning Report: Beyond the Pearls. Ed. Dasgupta R and Koolaee RM. (Pending book publication, September 2015)
Campese VC and Lakdawala RS. “The Challenges of Blood Pressure Control in Dialysis Patients.” Clinical Dialysis. Ed. Nissenson AR and Fine RN. (Pending book punlication, 2015)

Abstracts and Presentations

Lakdawala RS, Wachterman M. Symptomatic Anemia Due to Gastric Invasion of Hepatocelluar Carcinoma. Oral Presentation at Senior Research Academic Day, Boston University School of Medicine; 2014 June 6; Boston, MA
Ghaffari A, Lakdawala RS. “Peritoneal Dialysis Solution Shortage: A Short-term Management Strategy.” Presented at Quality Improvement Slide Forum at Annual Dialysis Conference; 2015 Feb 2; New Orleans, CA.

Volunteer Experience

2012-2014	Peer Mentor Boston University Internal Medicine Residency Program Boston, MA
2012-2014	Developer- Internal Medicine Intern Handbook Boston University Internal Medicine Residency Program Boston, MA

Languages

English – Fluent written and spoken
Spanish –Fluent written and spoken
Gujarati – Conversational